OPKO Health, Inc.’s OPK company, ModeX Therapeutics Inc., announced the dosing of the first participant in the Phase I study ...

A person on board a plane at Boston Logan International Airport that was taxiing for takeoff suddenly opened an exit door and ...

The past year has been a very busy one for privately-held Dewpoint Therapeutics, a Boston firm founded in 2018 that focuses ...

AI, an artificial intelligence (AI) innovator disrupting the pharmaceutical arena, today announced that Merck KGaA, Darmstadt ...

CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for ...

MSD has spent €500M acquiring a Dundalk vaccine plant and several other facilities around Ireland in an early year boost for ...

Recognizing the increased use of artificial intelligence in the development of new therapies, the U.S. FDA on Monday released ...

The theory is solid, but creating such a bespoke vaccine quickly enough to be of use is a different matter. “Not many years ...

New York City police say they’ve identified the woman who died earlier this month after being set on fire while asleep in a ...

Listen and subscribe to Stocks In Translation on Apple Podcasts, Spotify, or wherever you find your favorite podcast. In this ...

Boston, Massachusetts-based Sonde Health – a PureTech Health company – has previously tested the technology as a diagnostic for respiratory diseases. Prior studies have shown that with only ...

The drug, according to Merck, is the first and only PARP inhibitor—a type of medication that “causes a disruption in the way that [patients’] cells work,” Marks explains—to improve ...